The French DATAML registry study by the Toulouse–Bordeaux group included 160 patients with FLT3-ITD mutation-positive R/R AML [26], while other studies were performed in smaller patient populations [27,28]. The gene discussed is FLT3; the disease is acute myeloid leukemia.